NEW ROCHELLE, NY - The Medical Letter Inc., publisher of The Medical Letter on Drugs and Therapeutics, announces the release of its newest handbook Drugs of Choice 2018.
Drugs of Choice 2018 includes the latest information on drugs for treating some of the most common conditions seen in everyday practice, including type 2 diabetes, hypertension, allergic disorders, asthma, COPD, postmenopausal osteoporosis, cognitive loss and dementia, migraine, opioid use disorder, Parkinson’s disease, epilepsy, and sexually transmitted infections, in a convenient pocket-sized handbook.
"The new Drugs of Choice 2018 is concise, with much of the information presented in charts and tables for quick reference." said Jean-Marie Pflomm, Editor in Chief. "The reviews cover first-choice and alternative drugs, with actionable recommendations so providers can choose the best drugs for their patients without any influence from the pharmaceutical industry."
"Additional products available from The Medical Letter include The Medical Letter Site License, The Medical Letter Continuing Medical Education program, A Searchable Collection, and Drug Interactions from The Medical Letter online database. All products are valuable sources of reliable, objective, and unbiased drug information.
The Medical Letter, Inc. is a nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases in its newsletter, The Medical Letter on Drugs and Therapeutics. The Medical Letter, Inc., is supported entirely by subscriber fees and is based in New Rochelle, NY. For more information call (800) 211-2769 or go to www.medicalletter.org.
Executive Director of Marketing & Communications
The Medical Letter Inc.
145 Huguenot St., Suite 312
New Rochelle, NY 10801
Phone: 914.235.0500 Ext. 345
joanne@medicalletter.org